Tuesday, September 01, 2020

Vaccine narrows racial disparities in pneumococcal disease

https://www.eurekalert.org/pub_releases/2020-08/vumc-vnr083120.php

News Release 31-Aug-2020
Vanderbilt University Medical Center

In a major public health success, the introduction of pneumococcal conjugate vaccine PCV13, or Prevnar 13, in 2010 in the United States is associated with reduction in socioeconomic disparities and the near elimination of Black-white-based racial disparities for invasive pneumococcal disease.

•••••


No comments:

Post a Comment